中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 11
Nov.  2020
Turn off MathJax
Article Contents

Implementation of aerobic exercise intervention in patients with metabolic associated fatty liver disease:A prospective study

DOI: 10.3969/j.issn.1001-5256.2020.11.014
Research funding:

 

  • Received Date: 2020-04-10
  • Published Date: 2020-11-20
  • Objective To investigate the intervention effect of moderate-intensity aerobic exercise on patients with metabolic associated fatty liver disease( MAFLD) and preliminary intervention regimens,and to provide a theoretical basis and new ideas for the effective prevention and treatment of MAFLD. Methods A total of 158 MAFLD patients who underwent physical examination in Health Management Center of Sichuan Provincial People's Hospital from May to August 2019 or who were recruited through the WeChat official account of“Health Management Center of Sichuan Provincial People's Hospital”were enrolled as subjects,and the patients were divided into control group with 52 patients,monthly follow-up group with 54 patients,and weekly follow-up group with 52 groups using a random number table. The patients in the control group were given health education alone on admission,and those in the monthly follow-up group and the weekly follow-up group were received the intervention of moderate-intensity aerobic exercise; in the monthly follow-up group and the weekly follow-up group,a sports bracelet was used to monitor the exercise and follow-up was performed through the WeChat platform at a frequency of once a month and once a week,respectively. The noninvasive liver fibrosis diagnosis system FibroTouch was used to evaluate the degree of fatty liver disease before and after intervention. The three groups were compared in terms of the changes in body mass index( BMI),waist circumference,hepatic fat attenuation index,liver stiffness,blood pressure,aspartate aminotransferase,alanine aminotransferase( ALT),gamma-glutamyl transpeptidase( GGT),fasting plasma glucose( FPG),uric acid( UA),total cholesterol( TG),triglyceride( TG),low-density lipoprotein cholesterol,and high-density lipoprotein cholesterol after 3 months of intervention. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups,and the paired t-test was used for comparison between two groups; the Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups,and the Nemenyi test or Wilcoxon signed rank-sum test was used for comparison between two groups. Results A total of 147 patients completed the trial,with 49 patients in the control group( 3 were lost to follow-up),49 in the monthly follow-up group( 5 were lost to follow-up),and 49 in the weekly follow-up group( 3 were lost to follow-up). With the amount of exercise,which reached the target heart rate,5 times a week for more than 30 minutes each time as the criteria,the rate of reaching the standard was 66. 7% in the monthly follow-up group and 93. 2% in the weekly follow-up group. There were no significant differences in each index between the three groups before intervention( all P > 0. 05). The monthly follow-up group had a significant reduction in waist circumference after intervention( 93. 39 ± 9. 24 cm vs 94. 24 ± 8. 89 cm,t = 2. 590,P < 0. 05). After intervention,the weekly follow-up group had significant reductions in BMI( 26. 46 ± 3. 36 kg/m2 vs 27. 63 ± 3. 46 kg/m2,t =8. 534,P<0. 001),waist circumference( 87. 04 ±8. 84 cm vs 91. 47 ±8. 08 cm,t =6. 854,P <0. 001),hepatic fat attenuation index( 260. 08 ± 31. 07 d B/m vs 287. 88 ± 23. 28 d B/m,t = 8. 521,P < 0. 001),diastolic blood pressure( 76. 78 ±11. 23 mm Hg vs 79. 27 ± 12. 36 mm Hg,t = 2. 106,P = 0. 040),ALT [32( 20-43) U/L vs 43( 28-59) U/L,Z =-3. 973,P <0. 001],GGT [25( 19-40) U/L vs 34( 24-47) U/L,Z =-3. 847,P < 0. 001],TG [1. 48( 1. 20-2. 02) mmol/L vs 2. 04( 1. 63-2. 80) mmol/L,Z =-3. 873,P < 0. 001],UA( 381. 53 ± 71. 89 μmol/L vs 414. 37 ± 81. 27 μmol/L,t = 3. 953,P < 0. 001),and FPG( 5. 05 ± 0. 58 mmol/L vs 5. 21 ± 0. 71 mmol/L,t = 2. 185,P = 0. 034). Conclusion Moderate-intensity aerobic exercise can significantly reduce the serum levels of TG,ALT,and GGT and alleviate the degree of fatty liver disease in MAFLD patients,and weekly follow-up has a better management effect than monthly follow-up. The method of remote management based on sports bracelet and We Chat software is simple and easy,with a high level of acceptance among MAFLD patients.

     

  • loading
  • [1] KIRTI D,KANCHAN M,ASHU SB,et al. Effect of progressive resistance exercise training on hepatic fatin asian indians with non-alcolic fatty liver disease[J]. British J Med Med Res,2014,4(1):114-124.
    [2] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):939-946.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):939-946.
    [3] OH S,SO R,SHIDA T,et al. High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease[J]. Sci Rep,2017,7:43029.
    [4] ARORA C,MALHOTRA A,RANJAN P,et al. Lifestyle intervention framework for obese patients with non-alcoholic fatty liver disease-a tool for health professionals in resource constraint settings[J]. Cureus,2019,11(10):e5999.
    [5] YASUTAKE K,KOHJIMA M,KOTOH K,et al. Dietary habits and behaviors associated with nonalcoholic fatty liver disease[J]. World J Gastroenterol,2014,20(7):1756-1767.
    [6] SCHWIMMER JB,UGALDE-NICALO P,WELSH JA,et al.Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys:A randomized clinical trial[J]. JAMA,2019,321(3):256-265.
    [7] YU Y,ZHU L,HU M,et al. Green therapy for nonalcoholic fatty liver disease in recent five years[J]. J Milit Physic Educ Sports,2016,35(4):101-104.(in Chinese)于洋,朱琳,胡敏,等.近五年非酒精性脂肪肝运动疗法的研究进展[J].军事体育学报,2016,35(4):101-104.
    [8] RINELLA ME. Nonalcoholic fatty liver disease:A systematic review[J]. JAMA,2015,313(22):2263-2273.
    [9] YKI-JARVINEN H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome[J]. Lancet Diabetes Endocrinol,2014,2(11):901-910.
    [10] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64(1):73-84.
    [11] VERNON G,BARANOVA A,YOUNOSSI ZM. Systematic review:The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J]. Aliment Pharmacol Ther,2011,34(3):274-285.
    [12] FAN JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J]. J Gastroenterol Hepatol,2013,28(Suppl 1):11-17.
    [13] European Association for the Study of the Liver(EASL),European Association for the Study of Diabetes(EASD),European Association for the Study of Obesity(EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J]. J Hepatol,2016,64(6):1388-1402.
    [14] HASHIDA R,KAWAGUCHI T,BEKKI M,et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease:A systematic review[J]. J Hepatol,2017,66(1):142-152.
    [15] JOHNSON NA,SACHINWALLA T,WALTON DW,et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss[J]. Hepatology,2009,50(4):1105-1112.
    [16] SULLIVAN S,KIRK EP,MITTENDORFER B,et al. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease[J]. Hepatology,2012,55(6):1738-1745.
    [17] KATSAGONI CN,GEORGOULIS M,PAPATHEODORIDIS GV,et al. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease:A metaanalysis[J]. Metabolism,2017,68:119-132.
    [18] THOMPSON D,MARKOVITCH D,BETTS JA,et al. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men:A randomized-controlled trial[J]. J Appl Physiol(1985),2010,108(4):769-779.
    [19] OH S,TANAKA K,WARABI E,et al. Exercise reduces inflammation and oxidative stress in obesity-related liver diseases[J]. Med Sci Sports Exerc,2013,45(12):2214-2222.
    [20] OH S,TANAKA K,TSUJIMOTO T,et al. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease[J]. Metab Syndr Relat Disord,2014,12(5):290-298.
    [21] ZHANG HJ,HE J,PAN LL,et al. Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease:A randomized clinical trial[J]. JAMA Intern Med,2016,176(8):1074-1082.
    [22] ABDELBASSET WK,TANTAWY SA,KAMEL DM,et al. A randomized controlled trial on the effectiveness of 8-week highintensity interval exercise on intrahepatic triglycerides,visceral lipids,and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease[J]. Medicine(Baltimore),2019,98(12):e14918.
    [23] GUO R,LIONG EC,SO KF,et al. Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease[J]. Hepatobiliary Pancreat Dis Int,2015,14(2):139-144.
    [24] CHO J,LEE I,KIM D,et al. Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice[J]. J Exerc Nutrition Biochem,2014,18(4):339-346.
    [25] MAROSI K,BORI Z,HART N,et al. Long-term exercise treatment reduces oxidative stress in the hippocampus of aging rats[J]. Neuroscience,2012,226:21-28.
    [26] KAWANISHI N,YANO H,MIZOKAMI T,et al. Exercise training attenuates hepatic inflammation,fibrosis and macrophage infiltration during diet induced-obesity in mice[J]. Brain Behav Immun,2012,26(6):931-941.
    [27] FEALY CE,HAUS JM,SOLOMON TP,et al. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease[J]. J Appl Physiol(1985),2012,113(1):1-6.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (4551) PDF downloads(112) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return